Health Care Equipment & Supplies · NYSE

RMDResmed Inc

Last close
$239.53 +0.3%
52-week range
$180.26 to $277.67
Market cap
$33.7B
Next earnings
Not scheduled

Fiscal 2026 at a glance

Revenue
$5.65B
+10% vs FY25
Net income
$1.52B
+9% vs FY25
Free cash flow
$1.65B
-1% vs FY25
Net cash
$810M
Cash $1.47B, debt $659M

Stock price

+285% since Dec 2016

Valuation vs its own 10 years

Below its 10-year median on all 4 multiples

Where each multiple sits today inside its own range since 2016, measured at every quarter end. The thin tick is the median.

P/E, trailing
21.8x
18.7x77.5x
8th percentile, below its median of 36.7x
Price / sales
5.9x
4.5x11.6x
22nd percentile, below its median of 6.9x
EV / EBITDA
15.8x
13.2x35.5x
8th percentile, below its median of 22.8x
Price / free cash flow
20.9x
17.2x143x
10th percentile, below its median of 34.9x

Key statistics

Trailing 12 months unless noted, through the quarter ending 2026-09-30. Every figure carries its unit.

Valuation

P/E
21.8x
Earnings yield
4.6%
Price / sales
5.9x
Price / book
5.7x
Price / operating cash flow
19.0x
EV / EBITDA
15.8x
EV / sales
5.8x
Free cash flow yield
4.8%

Profitability

Gross margin
61.1%
Operating margin
33.0%
Net margin
27.8%
Return on equity
26.8%
Return on capital
23.6%

Growth per year

Revenue, 3 years
+10.2%
Revenue, 5 years
+12.1%
Revenue, 9 years
+11.8%
EPS, 3 years
+19.6%

Balance sheet

Cash and investments
$1.01B
Total debt
$410M
Net cash
$601M
Debt / equity
0.07x
Current ratio
2.65x

Shares and dividend

Shares outstanding
141M
Share count, 5 years
-0.3%
Beta, 1 year
0.49
Dividend yield
1.0%
Dividend per share, TTM
$2.46
Payout ratio
22.4%

Ten years of the business

Last 40 quarters, fiscal 2017 to 2026 and after. Hover a bar for its quarter.

Revenue and net incomeLatest quarter $1.41B
RevenueNet income
Gross profitLatest quarter $871M
EBITDALatest quarter $495M
Margins62 / 32 / 30%
GrossOperatingNet
Earnings per shareLatest quarter $2.92
Cash flowLatest quarter $422M
OperatingCapexFree
Cash vs debtLatest quarter $1.01B
Cash and investmentsTotal debt
P/E historyNow 21.8x
P/E, median 36.7x dashed
P/S historyNow 5.9x
P/S, median 6.9x dashed

Where the revenue comes from

Sleep and Breathing Health went from 88% to 88% of revenue in 3 years

Share of revenue by product line, fiscal 2023 to 2026, as reported in the 10-K.

Sleep and Breathing HealthResidential Care Software
FY23
88%12%
$4.22B
FY24
88%12%
$4.69B
FY25
88%12%
$5.15B
FY26
88%12%
$5.65B
Fiscal 2026 by product line
Product lineRevenueSharevs FY25
Sleep and Breathing Health$4.98B88.0%+10%
Residential Care Software$676M12.0%+5%

Health Care Equipment & Supplies peers

The largest names in the same industry that we cover, all in US dollars. The last column applies the same history test to each peer.

CompanyMarket capRevenue growth Operating marginP/EP/SP/E vs own history
ABT Abbott Laboratories $188B +10% 13.8%40.4x3.9x 60th percentile
DHR Danaher Corp $164B +6% 20.4%38.1x6.4x 65th percentile
ISRG Intuitive Surgical Inc $154B +20% 28.4%53.7x13.3x 48th percentile
MDT Medtronic plc $132B +10% 18.1%25.3x3.5x 20th percentile
SYK Stryker Corp $118B +8% 20.7%33.0x4.5x 30th percentile
RMD Resmed Inc $33.7B +9% 33.0%21.8x5.9x 8th percentile

The company

Sector
Health Care
Industry
Health Care Equipment & Supplies
CEO
Michael Farrell
Founded
1989
Headquarters
San Diego, CA
Fiscal year ends
June
Website
resmed.com

What it does

Resmed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

Description from Wikipedia (CC BY-SA).

Around the numbers

What the rest of EdgeStacker knows about RMD.

Next report

No confirmed report date in the next 95 days yet.

Open the Earnings Hub
Big funds, latest 13F

Held by 599 active funds. Crowd level: quiet.

Open the Smart money tab